Labor analgesia
Conditions
Interventions
a:Continuous epidural infusion of ropivacaine 2ml/h, pulse 12ml, patient-controlled epidural administration of 12ml
b:Ropivacaine pulse 12ml, patient-controlled epidural administration 12ml
c:Patient-controlled epidural administration of ropivacaine 12ml
d:Patient-controlled epidural administration of ropivacaine combined with sufentanil 0.25µg/ml was 12ml
e:Continuous epidural infusion of ropivacaine combined with sufentanil 0.25µg/ml 6ml/h patient-controlled epidural administration of 12ml
f:Ropivacaine combined with sufentanil 0.25µg/ml epidural continuous infusion of 6ml/h patient-controlled epidural administration of 8ml
Sponsors
Benxi Central Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: ASAI-II, 20 to 40 years old, primiparous, singlet pregnancy, head position, 37 to 42 weeks gestation, height 155cm to 170cm, epidural labor analgesia and signed informed consent were required.
Exclusion criteria
Exclusion criteria: (1) Twin pregnancy; Women with multiple births. (2) Intraspinal labor analgesia contraindications, allergy to opioids or ropivacaine. (3) History of neuropsychiatric diseases, high-risk pregnancy (placental abruption, placenta previa, preeclampsia); Gestational diabetes mellitus, BMI >35 kg/m2. (4) Receive opioids or sedatives within 4 hours before epidural analgesia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score; | — |
Countries
China
Contacts
Public ContactPeiyang Yan
Benxi Central Hospital of Liaoning Province
Outcome results
None listed